Xenitra Limited (XEN) Fair Value & Analysis
Consumer Cyclical · AU · Market cap A$11.6M
Fair value as of: Jun 26, 2026
From 3 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from A$0.0100 to A$0.0032 (−67.9%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range A$0.0020 – A$0.0040 · fair‑value band A$0.0032 – A$0.0035 · the A$0.0030 price screens below the A$0.0032 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Xenitra Limited (XEN) currently trades at A$0.0030, while our model-based Fair Value estimate is A$0.0032 — implying the stock looks roughly 7.0% undervalued today. We read business quality at 44/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, Xenitra Limited generated revenue of A$33.9M at a net margin of -11.7%. Revenue declined 43.9% year over year. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Xenitra Limited engages in the sale of various products through its online e-commerce store in Australia, Hong Kong, Mainland China, and New Zealand. It offers beverages and alcohol; food products, including dairy, fresh fruits, seafood, honey, wine, beef, mutton, and lamb; and health and beauty products, such as vitamins, protein shakes/meal replacement shakes, supplements, herbs/herbal teas, skincare, haircare, and make up products. The company also provides fashion, homewares, art and craft, metal work, and leatherwear; and health and wellbeing products comprising vitamins, nutritional and mineral supplements, and non-prescription medicines, as well as various drugs made in Australian and New Zealand laboratories. In addition, it provides international importing, exporting, and warehousing, as well as freight and logistics support services. Further, the company offers marketing services, which include brand strategy development, omnichannel marketing campaign creation, live …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Xenitra Limited reported revenue of A$39.8M in FY2025 versus A$12.4M in FY2021, a compound +33.7%/yr. Reported net income was −A$3.5M in FY2025.
Is XEN fairly valued? → Check now
Similar stocks
6 more Department Stores stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Aeon Co AONNY | $8.02 | $4.68 | -42% |
| Falabella S.A FALABELLA | 5,899 CLP | 8,880 CLP | +51% |
| SM Investments Corporation SVTMF | $10.15 | $21.80 | +115% |
| Ryohin Keikaku Co RYKKY | $11.15 | $6.53 | -41% |
| Shoprite Holdings SRGHY | $18.32 | $18.67 | +2% |
| Marks and Spencer Group MAKSY | $9.33 | $12.57 | +35% |
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Xenitra Limited (XEN) undervalued?
What is the fair value of XEN?
What is the quality score of XEN?
What is the revenue of Xenitra Limited (XEN)?
What is the net profit margin of XEN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.